Results 261 to 270 of about 184,260 (294)
Some of the next articles are maybe not open access.
Best Practice & Research Clinical Haematology, 2001
Precursor B-ALL (BCP-ALL) is associated with a good outcome in children. Cytogenetics is one of the gold standards for risk stratification for treatment that has contributed to improved survival. Although in T-ALL genetic analysis has not been used to guide therapy, it has contributed significantly to the understanding of the biology.
openaire +5 more sources
Precursor B-ALL (BCP-ALL) is associated with a good outcome in children. Cytogenetics is one of the gold standards for risk stratification for treatment that has contributed to improved survival. Although in T-ALL genetic analysis has not been used to guide therapy, it has contributed significantly to the understanding of the biology.
openaire +5 more sources
Leukemia cutis in acute lymphoblastic leukemia
Journal of the American Academy of Dermatology, 1994separating normal epidermis from a diffuse dermal infiltrate of lymphoid blast cells with round and regular nuclei, inconspicuous nucleoli, and scanty, moderately basophilic cytoplasm. Immunophenotype analysis revealed strong positivity for CD 10.The patient wastreated with methotrexate, teniposide, cytosine arabinoside, and local irradiation, and a ...
J F, de Lacerda +5 more
openaire +2 more sources
Acute Lymphoblastic Leukemia: Background
2003Acute lymphoblastic leukemia is a fascinating disease for the cytogeneticist, as so many cases have a clone detectable by cytogenetics or FISH, and because identifying the abnormalities provides such useful information to the clinician. However, it is also a frustrating disease, as it has technical challenges such as a marked tendency for the sample to
openaire +2 more sources
2007
Acute lymphoblastic leukemias (ALLs) are a group of hematological neoplasias defined by cytomorphology, cytochemistry, immunological markers, and more recently, molecular markers. The prognosis of ALL has much improved in the last 30 yr, especially in the age group between 2 and 10 yr, where most patients can be cured by chemotherapy.
Reinhold Munker, Vishwas Sakhalkar
openaire +1 more source
Acute lymphoblastic leukemias (ALLs) are a group of hematological neoplasias defined by cytomorphology, cytochemistry, immunological markers, and more recently, molecular markers. The prognosis of ALL has much improved in the last 30 yr, especially in the age group between 2 and 10 yr, where most patients can be cured by chemotherapy.
Reinhold Munker, Vishwas Sakhalkar
openaire +1 more source
Relapsed acute lymphoblastic leukemia
American Journal of Ophthalmology, 2021Judy L. Chen +2 more
openaire +2 more sources
Acute leukemia in adults: recent developments in diagnosis and treatment
Ca-A Cancer Journal for Clinicians, 1994Richard A Larson
exaly
Acute lymphoblastic leukemia (ALL)
Best Practice & Research Clinical Haematology, 2017openaire +2 more sources
Seminars in radiation oncology
Acute lymphoblastic leukemia (ALL) accounts for 25% of childhood cancer. Clinical and biological parameters define prognostic categories and therapeutic approaches. For the majority of children with B-progenitor ALL, age (1-9 yrs) and white blood count (WBC50,000 and age>9 yrs. define eligibility for high-risk protocols. Infants (50,000; other criteria
openaire +1 more source
Acute lymphoblastic leukemia (ALL) accounts for 25% of childhood cancer. Clinical and biological parameters define prognostic categories and therapeutic approaches. For the majority of children with B-progenitor ALL, age (1-9 yrs) and white blood count (WBC50,000 and age>9 yrs. define eligibility for high-risk protocols. Infants (50,000; other criteria
openaire +1 more source